Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice
Authors
Keywords
-
Journal
CLINICAL SCIENCE
Volume 133, Issue 15, Pages 1705-1720
Publisher
Portland Press Ltd.
Online
2019-07-23
DOI
10.1042/cs20190585
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Naringenin Attenuates Myocardial Ischemia-Reperfusion Injury via cGMP-PKGIα Signaling and In Vivo and In Vitro Studies
- (2019) Li-Ming Yu et al. Oxidative Medicine and Cellular Longevity
- SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
- (2019) Chenguang Li et al. Cardiovascular Diabetology
- Melatonin protects diabetic heart against ischemia-reperfusion injury, role of membrane receptor-dependent cGMP-PKG activation
- (2018) Li-ming Yu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
- (2018) N.H. Cho et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Isosteviol ameliorates diabetic cardiomyopathy in rats by inhibiting ERK and NF-κB signaling pathways
- (2018) Sheng-Gao Tang et al. JOURNAL OF ENDOCRINOLOGY
- Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy
- (2018) Thomas H. Marwick et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- NLRP3: A Novel Mediator in Cardiovascular Disease
- (2018) Wenyi Zhou et al. Journal of Immunology Research
- Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
- (2018) Hao Zhou et al. Redox Biology
- RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy
- (2018) Zongshun Huang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes
- (2018) Kwong-Man Ng et al. Scientific Reports
- (Pro)renin Receptor Is an Amplifier of Wnt/ β -Catenin Signaling in Kidney Injury and Fibrosis
- (2017) Zhen Li et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
- (2017) Beibei Luo et al. Frontiers in Physiology
- Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects
- (2017) Ioanna Andreadou et al. Frontiers in Physiology
- The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
- (2017) Sebastian Steven et al. Redox Biology
- Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome
- (2016) Hiroaki Kusaka et al. Cardiovascular Diabetology
- The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE −/− mice fed a western diet
- (2016) Ji Hye Han et al. DIABETOLOGIA
- Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
- (2016) Antonius Baartscheer et al. DIABETOLOGIA
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
- (2016) Xing Liu et al. NATURE
- Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms
- (2015) Zhenwei Shi et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Palmitate promotes autophagy and apoptosis through ROS-dependent JNK and p38 MAPK
- (2015) Jing Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism
- (2015) Javier Inserte et al. BRITISH JOURNAL OF PHARMACOLOGY
- The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus
- (2015) Csaba Mátyás et al. Cardiovascular Diabetology
- Diabetic Cardiovascular Disease Induced by Oxidative Stress
- (2015) Yosuke Kayama et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mitochondrial Lon protease controls ROS-dependent apoptosis in cardiomyocyte under hypoxia
- (2015) Chan-Yen Kuo et al. MITOCHONDRION
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
- (2015) Jianjin Shi et al. NATURE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls
- (2015) Anne Pernille Ofstad et al. Journal of Diabetes
- KCa3.1/IK1 Channel Regulation by cGMP-Dependent Protein Kinase (PKG) via Reactive Oxygen Species and CaMKII in Microglia: An Immune Modulating Feedback System?
- (2015) Roger Ferreira et al. Frontiers in Immunology
- Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
- (2014) Bowen Lin et al. Cardiovascular Diabetology
- Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction
- (2014) Dong Fan et al. CARDIOVASCULAR RESEARCH
- Protein kinase RNA- like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)- mediated endoplasmic reticulum stress- induced apoptosis in diabetic cardiomyopathy
- (2013) Zhong-Wei Liu et al. Cardiovascular Diabetology
- Production of Reactive Oxygen Species in the Diabetic Heart
- (2013) Yasushi Teshima et al. CIRCULATION JOURNAL
- Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis
- (2013) Xiao Sun et al. FOOD AND CHEMICAL TOXICOLOGY
- Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community
- (2011) Jithendra B Somaratne et al. Cardiovascular Diabetology
- Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
- (2011) R. Grempler et al. DIABETES OBESITY & METABOLISM
- Intensive glycemic control and cardiovascular disease: an update
- (2010) Aparna Brown et al. Nature Reviews Cardiology
- Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
- (2010) Bianca C. Bernardo et al. PHARMACOLOGY & THERAPEUTICS
- Glucose Control by the Kidney: An Emerging Target in Diabetes
- (2009) Olivera Marsenic AMERICAN JOURNAL OF KIDNEY DISEASES
- Expression of constitutively active cGMP-dependent protein kinase inhibits glucose-induced vascular smooth muscle cell proliferation
- (2009) Shuxia Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
- Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics
- (2009) Emily J. Tsai et al. PHARMACOLOGY & THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now